Emendo

3 stories about Emendo
מבחנה ביומד

AnGes laying off 110 EmendoBio employees three years after $250 million acquisition

20.12.23|Meir Orbach
The Japanese pharma company notified the employees of the Israeli firm that they are being fired and the future of the company's technology is unclear at this point
Rachel Diamant Emendo

“Innovation and groundbreaking innovation is really mind blowing. … That’s what inspires me today.”

31.08.21|CTech
Rachel Diamant, chief IP officer & head of pipeline development at Emendo Biotherapeutics joins Michael Matias to discuss biology and innovation
מעבדה רפואה 1 זירת הבריאות

Gene Therapy Company Emendo Biotherapeutics Raises $61 Million

16.01.20|Adi Pick
Emendo uses protein engineering to treat certain genetic disorders and diseases